Noscendo raises €6.8M Series A round
11 November 2020· Duisburg, Germany· health, diagnostics, ai, biotech, b2b, pure_software
The funding will be used to further develop and scale the DISQVER diagnostic platform, accelerate its market entry, and expand clinical validation across various medical indications.
Investors
LeadEarlybird Venture Capital
Also participating
High-Tech GründerfondsPaua VenturesWieland Capital
About Noscendo
Stage
Growth
Headquarters
Duisburg, Germany
Founded
2017
Team Size
21–50
Sectors
healthdiagnosticsaibiotechb2bpure_software